One of the greatest challenges in applying NGS to clinical research is ensuring that you are generating relevant results from your precious samples. Wading through the vast amount of data generated from NGS to find the actionable content can be daunting. One solution is the use of targeted gene panels that enable you to focus… Read article →
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples Hilden, Germany, and Germantown, Maryland, June 1, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its liquid biopsy workflow for clinical cancer research using QIAGEN’s GeneReader NGS System for next-generation sequencing (NGS). The Actionable Insights… Read article →
Meet us there to discuss how our next-generation oncology solutions can take you from sample to result ASCO is just around the corner, and we’re looking forward to seeing you from June 3–7 in Chicago! The theme of this year’s meeting is “Collective wisdom: The future of patient-centered care and research”. Here at QIAGEN, we… Read article →
Leisa Jackson – A Comparison of QIAamp and QIAsymphony for Liquid Biopsy Sample Extraction
View Video →
